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The Mitogen-Induced Increase in T Cell Size
Involves PKC and NFAT Activation
of Rel/NF-B-Dependent c-myc Expression
pathway comprise dimers of related proteins (c-Rel,
RelA(p65), RelB, p50NF-B1, and p52NF-B2) that bind
consensus B elements within the regulatory regions of
target genes (Baldwin, 1996). In most cells, the main
pool of Rel/NF-B is sequestered to the cytoplasm by
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inhibitory proteins (IBs). Diverse stimuli, including mito-1G Royal Parade
gens, induce Rel/NF-B nuclear import by activatingParkville, Victoria 3050
an IB kinase (IKK) complex that phosphorylates IBAustralia
proteins (Karin, 1999), targeting them for ubiquitin-2 Department of Surgery
dependent proteosome-mediated degradation (White-University of Melbourne
side and Israel, 1997). Members of the NFAT familyParkville, Victoria 3050
of transcription factors (NFATC1, NFATC2, NFATC3,Australia
NFATC4, NFATC5) also pre-exist in the cytoplasm and3 John Curtin School of Medical Research
are translocated to the nucleus in response to calcium-Australian National University
dependent signals that lead to NFAT dephosphorylationCanberra 2601
by calcineurin (Rao et al., 1997). Nuclear NFAT proteinsAustralian Capital Territory
bind regulatory elements within target genes in a coop-Australia
erative fashion with other transcription factors, most
notably AP-1 proteins (Rao et al., 1997).
During T cell activation, different Rel/NF-B dimersSummary
enter the nucleus in a temporal fashion. In resting cells,
only NF-B1 homodimers are detected in the nucleusCell growth during the G1 stage of the cell cycle is
(Bryan et al., 1994). Within 30 min of stimulation, NF-partly controlled by inducing c-myc expression, which
B1/RelA (p50/p65) heterodimers are translocated toin B cells is regulated by the NF-B1 and c-Rel tran-
the nucleus from the cytoplasm, whereas significantscription factors. Here, we show that c-myc-depen-
nuclear levels of c-Rel are only detected 90 min post-dent growth during T cell activation requires c-Rel and
activation (Molitor et al., 1990; Venkataraman et al.,RelA and that blocking this growth by inhibiting protein
1996). Although some c-Rel resides in the cytoplasm ofkinase C theta (PKC) coincides with a failure to upreg-
unstimulated T cells, most of this c-Rel pool is not rapidlyulate c-myc due to impaired RelA nuclear import and
mobilized in response to mitogenic signals (Venkatara-inhibition of NFAT-dependent c-rel transcription.
man et al., 1995). Instead, nuclear c-Rel expression ap-These results demonstrate that different Rel/NF-B
pears to follow the transcriptional induction of c-rel (Gru-dimers regulate the mitogenic growth of mature T and
mont and Gerondakis, 1990), a finding consistent withB cells, with a signaling pathway incorporating PKC
its nuclear localization during T cell activation beingand NFAT controlling c-Rel/RelA-induced c-myc ex-
dependent on new c-Rel synthesis (Venkataraman etpression in activated T cells.
al., 1995, 1996). NFATC1 and NFATC2 are the major
NFAT isoforms expressed in peripheral T cells (Rao etIntroduction
al., 1997). There is no evidence for the temporal nuclear
import of different NFAT proteins during T cell activation.TCR and costimulatory receptor engagement initiate a
Gene targeting has revealed the essential roles served
signaling cascade in T cells that induces changes in
by individual Rel/NF-B and NFAT proteins during T cell
gene expression, culminating in these cells becoming
activation (Gerondakis et al., 1999; Graef et al., 2001).
immune effectors. During T cell activation, entry of qui- TCR/CD28-costimulated c-rel/T cells exhibit impaired
escent lymphocytes into the cell cycle is accompanied G1/S phase progression resulting from reduced IL-2
by an increase in biomass and size. This event, termed transcription (Kontgen et al., 1995). This defect is mito-
blast formation or cell growth, is intimately linked with gen dependent, as it is largely overcome by PMA plus
increased RNA and protein expression that occurs prior ionomycin stimulation. T cells lacking NF-B1 exhibit a
to DNA synthesis (Conlon and Raff, 1999). Cell growth modest proliferative defect that is not rescued by provi-
and division are tightly coupled, with DNA synthesis sion of IL-2 (Zheng et al., 2001). Loss of RelA is reported
and division generally dependent on growth. Growth is to slightly diminish T cell proliferation (Zheng et al.,
thought to proceed throughout the G1 phase of the cell 2001). Due to functional overlap among these proteins,
cycle until threshold levels of certain cellular compo- essential roles ascribed to a particular Rel/NF-B pro-
nents that function as indicators of cell size trigger entry tein determined from the analysis of the corresponding
into S phase (Conlon and Raff, 1999). mutant mouse is likely to represent only part of its overall
Of the intracellular signaling networks implicated in function during T cell activation (Gerondakis et al., 1999).
T cell activation, many converge upon the Rel/NF-B Limited analysis of certain compound Rel/NF-B null
and NFAT pathways (Kane et al., 2002; Masuda et al., mutants has indeed established redundant roles for
1998). The transcriptional mediators of the Rel/NF-B these transcription factors in the T cell lineage (Gross-
man et al., 2000; Zheng et al., 2003). However, unlike
the essential role for Rel/NF-B during B cell ontogeny*Correspondence: gerondakis@wehi.edu.au
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Figure 1. T Cell Division Is Dependent on the
Rel/NF-B Pathway
Purified wt, nfkb1/, c-rel/, rela/, nfkb1/
c-rel/, nfkb1/rela/, and c-rel/rela/
T cells were stimulated for 48 hr with anti-
CD3/anti-CD28 mAbs in the absence (odd-
numbered lanes) or presence (even-numbered
lanes) of exogeneous IL-2.
(A) Cellular proliferation. T cell proliferation
was measured by [3H]thymidine incorpo-
ration.
(B) Cell cycle analysis. The fraction of viable
T cells in the S, G2, or M phases of the cell
cycle. Less than 1% of cells were in S or G2/M
prior to stimulation.
(Gugasyan et al., 2000), loss of Rel/NF-B function does proliferation (lane 11) was 10- and 30-fold less than
nfkb1/ and rela/ T cells. The most severe defectnot block the development of peripheral T cells (Hett-
mann et al., 1999). A similar theme of specific and redun- resulted from a combined loss of c-Rel and RelA, with
proliferation at levels only marginally higher than thatdant roles for the different NFAT family members during
T cell activation has emerged from the study of mutant observed for T cells in the absence of mitogen (lanes
13 and 14). Consistent with these trends, the frequencymice (Peng et al., 2001; Rengarajan et al., 2002). To
determine what new roles different Rel/NF-B proteins of cells in the S and G2/M phases of the cell cycle (Fig-
ure 1B) was markedly reduced in mitogen-stimulatedmight serve early in T cell activation and how this func-
tion is regulated, we examined mature T cells lacking nfkb1/c-rel/ (lanes 9 and 10) and nfkb1/rela/
(lanes 11 and 12) T cells (8% and 2%, respectively,various combinations of NF-B1, RelA, and c-Rel. Here
we show that c-Rel and RelA are essential for the c-Myc- compared with 40% in activated wt cells). No viable
rela/c-rel/ T cells were detected in S or G2/M (lanesdependent growth of mitogen-activated T cells and that
induced c-rel transcription, which preceeds c-myc ex- 13 and 14).
pression, is regulated by a PKC-NFAT-dependent
pathway. Mitogen-Induced T Cell Growth Is Blocked
in the Combined Absence of RelA and c-Rel
The failure of activated nfkb1/c-rel/ B cells to enterResults
S phase due to an inability to grow (Grumont et al., 2002)
prompted an examination of mitogen-induced growthRedundant Roles for Rel/NF-B during
Mitogen-Induced T Cell Activation by Rel/NF-B-deficient T cells. T cells were stimulated
in culture with anti-CD3/anti-CD28 Abs plus IL-2 andTo gain insight into what roles Rel/NF-B transcription
factors serve during T cell activation, T cells lacking growth measured after 24 hr by flow cytometry using
forward light scatter analysis. A typical set of data isNF-B1, c-Rel, RelA, or combinations of these proteins
were stimulated in culture with anti-CD3/anti-CD28 anti- shown in Figure 2A. Despite a reduced frequency of mito-
gen-stimulated nfkb1/, nfkb1/c-rel/, and nfkb1/bodies (Abs) in the absence or presence of exogenous
IL-2 over 48 hr. Splenic T cells were isolated from rela/ T cells entering S phase, their growth together
with that of c-rel/ and rela/ T cells appeared normal.rag-1/ mice engrafted with wild-type (wt), nfkb1/,
c-rel/, rela/, nfkb1/c-rel/, nfkb1/rela/, or In contrast, rela/c-rel/ T cells failed to undergo mito-
gen-induced growth. A growth block was also observedrela/c-rel/ E12 fetal liver hemopoietic progenitors.
This approach was adopted to ensure that the mitogenic after PMA plus ionomycin treatment (results not shown),
ruling out a stimulus-specific defect. Next, we examinedresponse of Rel/NF-B mutant T cells would not be
influenced by environmental differences during devel- if the failure of rela/c-rel/ T cells to increase in size
was associated with impaired RNA and protein syn-opment (Horwitz et al., 1997; Senftleben et al., 2001).
Proliferation was monitored by tritiated thymidine incor- thesis. Transcription, measured by 3H-uridine incorpora-
tion after the initial 12 hr period of stimulation with anti-poration (Figure 1A). The absence of RelA, as expected
(Zheng et al., 2001), had a minimal effect on proliferation CD3/anti-CD28 Abs (Figure 2B), established that rela/
c-rel/ T cells did not increase RNA synthesis upon(lanes 7 and 8). While impaired c-rel/T cell proliferation
(lane 5; Kontgen et al., 1995) was rescued by IL-2 (lane mitogenic activation. The protein content of mitogen-
activated rela/c-rel/ T cells also failed to increase6), the modest reduction in nfkb1/ T cell proliferation
was IL-2 independent (lanes 3 and 4). These defects above prestimulation levels (Figure 2C).
To ensure that the failure of mitogen-treated rela/were more pronounced in the absence of multiple Rel/
NF-B proteins. nfkb1/c-rel/ T cell proliferation (lane c-rel/ T cells to grow reflected a defect in activation
and not development, a cDNA encoding RelA was ex-9) was 3- and 5-fold lower, respectively, than that of
c-rel/ and nfkb1/ T cells, while nfkb1/rela/ T cell pressed in rela/c-rel/ T cells using retroviral-medi-
Rel/NF-B Control of c-myc-Dependent T Cell Growth
21
Figure 2. T Cell Growth Is Blocked in the Combined Absence of c-Rel and RelA
Quiescent Thy-1 wt, nfkb1/, c-rel/, rela/, nfkb1/c-rel/, nfkb1/rela/, and rela/c-rel/ splenic T cells untreated or activated in
culture with anti-CD3/anti-CD28 mAbs plus IL-2.
(A) Mitogen-induced growth of T cells lacking different Rel/NF-B proteins. After 24 hr, cells were examined by flow cytometry, with forward
light scatter profiles (x axis) of untreated (closed) and activated (open) cells shown on a linear scale being a measure of cell size. The data
are representative of three experiments.
(B) RNA synthesis in mitogen-activated T cells. RNA synthesis in wt (open bars), nfkb1/ (closed bars), c-rel/ (hatched bars), rela/ (reverse
hatched bars), nfkb1/c-rel/ (cross-hatched bars), nfkb1/rela/ (stippled bars), or rela/c-rel/ (gray bars) T cells that were untreated or
stimulated for 18 hr was measured by [3H]uridine incorporation. The data represents the mean  SD of three experiments.
(C) Protein levels in mitogen-treated T cells. Cellular protein levels were measured in equivalent numbers of viable purified wt, nfkb1/, c-rel/,
rela/, nfkb1/c-rel/, nfkb1/rela/, or rela/c-rel/ T cells left untreated (open) or stimulated (closed) for 24 hr. The results represent the
mean  SD of three experiments.
ated gene transfer. rag-1/ mice were engrafted with the redundant regulation of T cell growth by RelA and
c-Rel, rela/c-rel/ T cells transduced with MY-EGF-E12 rela/c-rel/ fetal liver hemopoietic progenitors
infected with MY-EGFP (control) or MY-EGFPrela virus. Prela but not pMY-EGFP now increased in size when
activated (Figure 3B).Western blotting of Thy-1GFP T cells from both
groups of reconstituted mice confirmed that RelA was We also noted that elevated levels of apoptosis ac-
companied the reduced proliferation of compound Rel/now expressed in T cells arising from progenitors in-
fected with MY-EGFPrela (Figure 3A). Consistent with NF-B mutant T cells (Supplemental Figure S1 at http://
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Figure 3. Increased Apoptosis in the Absence of RelA and c-Rel Does Not Influence T Cell Growth
(A) rela transgene expression in T cells. Equivalent numbers of GFPhiThy1 splenic T cells (boxed) isolated by FACS from rag-1/ mice
reconstituted with MY-EGFP or MY-EGFPrela virus-infected rela/c-rel/ hemopoietic progenitors were subjected to Western blotting using
anti-RelA and anti-HSP70 antibodies.
(B) rela transgene expression rescues the rela/c-rel/ T cell growth defect. Forward light scatter profiles of MY-EGFP- or MY-EGFPrela-
infected rela/c-rel/ GFPhiThy-1 splenic T cells cultured for 24 hr without (closed) and with (open) anti-CD3/anti-CD28 Ab stimulation.
(C) Mitogen-induced death of rela/c-rel/ T cells is inhibited by Bcl-2. The effect of transgenic Bcl-2 expression on the viability of wt and
rela/c-rel/ T cells that were untreated or activated in culture for 24 hr; more than 99% of cells were viable at T0.
(D) Bcl-2 fails to rescue the rela/c-rel/ T cell growth defect. Forward light scatter profiles of wt and rela/c-rel/ T cells expressing
transgenic Bcl-2, 24 hr after culture without (closed) or in response to (open) anti-CD3/anti-CD28 Ab activation. All results are representative
of two independent experiments.
www.immunity.com/cgi/content/full/21/1/19/DC1). Bcl-2 (lane 8). Importantly, despite Bcl-2 inhibiting mito-
gen-induced rela/c-rel/ T cell death, growth was stillTo rule out that the failure of activated rela/c-rel/
T cells to grow was not simply a consequence of these blocked (Figure 3D), indicating that T cell growth and
survival in response to mitogenic signals are indepen-cells being destined to undergo apoptosis, a bcl-2 trans-
gene was introduced onto the rela/c-rel/ genetic dently regulated by RelA and c-Rel.
background (Grossmann et al., 2000). Figure 3C shows
that while passive cell death of wt and rela/c-rel/ The Defect in Mitogen-Induced rela/c-rel/ T Cell
Growth Is Due to Impaired c-myc ExpressionT cells after 24 hr in culture was equivalent (lanes 1 and
2), the elevated levels of apoptosis in activated rela/ Since the block in nfkb1/c-rel/ B cell growth is a
direct consequence of reduced c-myc transcriptionc-rel/ T cell cultures (24 hr; lane 6) was inhibited by
Rel/NF-B Control of c-myc-Dependent T Cell Growth
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Figure 4. The Failure of Activated rela/c-rel/ T Cells to Grow Is Due to Impaired c-myc Expression
(A) Mitogen-induced c-myc expression is markedly reduced in rela/c-rel/ T cells. 10 g samples of total RNA isolated from wt, nfkb1/,
c-rel/, rela/, nfkb1/c-rel/, nfkb1/rela/, or rela/c-rel/ splenic T cells prior to stimulation or after anti-CD3/anti-CD28 Ab activation
for 1, 1.5, or 3 hr were subjected to Northern blot analysis. Filters were hybridized with c-myc and GAPDH cDNA probes. The data are
representative of three experiments.
(B) c-myc transgene expression in T cells. c-myc transgene and GAPDH expression was determined by semiquantitative RT-PCR performed
on RNA from equivalent numbers (5  104) of GFPhiThy1 splenic cells (boxed) isolated from rag-1/ mice reconstituted with MY-EGFP or
MY-EGFPc-myc virus-infected wt or rela/c-rel/ hemopoietic progenitors. The data are representative of four experiments.
(C) c-myc transgene expression rescues the rela/c-rel/ T cell growth defect. Forward light scatter profiles of MY-EGFP or MY-EGFPc-myc
virus-infected wt or rela/c-rel/ splenic T cells 24 hr after culture without (closed) or in response to anti-CD3/anti-CD28 Ab activation (open).
The data are representative of three experiments.
(Grumont et al., 2002), we examined c-myc expression T cells. rag-1/ mice were engrafted with wt or rela/
c-rel/ E12 fetal liver hemopoietic progenitors infectedin mitogen-activated rela/c-rel/ T cells (Figure 4A).
c-myc mRNA levels, undetectable in resting wt T cells with control (MY-EGFP) or c-myc-expressing (MY-
EGFPc-myc) murine retroviruses. GFP splenic T cells(lane 1), increased markedly within 90 min of stimula-
tion (lane 3) and were maintained at elevated levels for were isolated by flow cytometry 8 weeks after en-
graftment, and transgenic c-myc expression was exam-at least a further 90 min (lane 4). Whereas normal pat-
terns of c-myc expression were observed in resting and ined in Thy-1GFP wt and rela/c-rel/ splenic T cells
by semiquantitative RT-PCR using primers specific foractivated nfkb1/, c-rel/, rela/, nfkb1/c-rel/,
and nfkb1/rela/ T cells, c-myc mRNA levels in mito- retrovirus-encoded c-myc. Similar levels of transgenic
c-myc mRNA were detected in both wt and rela/gen-treated rela/c-rel/ T cells were not induced
above that observed in quiescent cells. c-rel/ T cells infected with MY-EGFPc-myc (Figure
4B). The effect of transgenic c-myc expression on T cellTo determine if the failure to upregulate c-myc expres-
sion accounted for the impaired growth of rela/c-rel/ growth is shown in Figure 4C. In the absence of mitogen,
wt and rela/c-rel/ T cells infected with MY-EGFPc-T cells, transgenic c-myc was expressed in mutant
Immunity
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myc, although equivalent in size, were larger than un- the nuclear expression of c-Rel, not RelA. Given that the
increased nuclear levels of c-Rel in T cells appearedstimulated cells of either genotype infected with MY-
to result from induced c-rel transcription, the temporalEGFP. Unstimulated MY-EGFPc-myc-infected cells also
association between the mitogenic induction of c-relexhibited greater size heterogeneity than infected con-
and c-myc expression prompted an examination of thetrols. As the degree of cell growth is influenced by the
pathway regulating c-rel expression in activated T cellslevel of c-myc expression (Grumont et al., 2002), this
and its links to growth.size heterogeneity most likely reflects clonal variation
First, the potential involvement of RelA in mitogen-in transgenic c-myc levels. Upon activation, wt but not
induced c-rel transcription was determined. Althoughrela/c-rel/ T cells infected with MY-EGFP increased
the nuclear translocation of pre-existing NF-B1/RelAin size. During a 24 hr period of activation, both MY-
precedes the induction of c-rel mRNA expression inEGFPc-myc-infected wt and rela/c-rel/ T cells un-
activated T cells (Rao et al., 2003) and constitutive c-relderwent an additional, equivalent increase in growth
transcription in B cells is dependent on Rel/NF-B regu-beyond that seen in these cells prior to stimulation. This
lation (Grumont et al., 1993), induced c-rel mRNA ex-extra growth may be due in part to increased levels
pression in anti-CD3/anti-CD28 Ab-activated nfkb1/of c-Myc protein resulting from a mitogen-dependent
rela/ splenic T cells was normal (Figure 6A). This ruledincrease in c-Myc stability (Grumont et al., 2002). The
out a requirement for NF-B in c-rel transcription.finding that transgenic c-myc expression was sufficient
The finding that the immunosuppressant FK506, anto overcome the block in mitogen-dependent rela/
inhibitor of calcineurin (Rao et al., 1997), blocked in-c-rel/ T cell growth are consistent with a growth defect
duced c-rel mRNA expression in activated T cells (Ven-arising from the inability to upregulate c-myc ex-
kataraman et al., 1995) raised the possibility that c-relpression.
transcription in T cells was regulated by an NFAT-depen-
dent pathway. Examination of the murine c-rel genePro-T Cell Growth and Division Is Normal
identified a putative NFAT binding site (5-TGGAAAin the Absence of c-Rel and RelA
GAGCTATGCCA-3), designated NFAT-R, 2305 nucleo-We had previously shown that thymocyte and peripheral
tides upstream of the major start site of transcriptionT cell numbers are reduced in the combined absence
(Figure 6B). Like bona fide NFAT elements, which com-of RelA and c-Rel (Grossman et al., 2000). Extensive
prise composite binding sites for NFATC and AP-1 orproliferation normally occurs within the CD25CD44
CREB/ATF proteins, NFAT-R perfectly matched the con-(stage IV) population of double-negative (DN) pro-T
sensus NFATC site and shared four of seven residuescells. Given the fact that Rel/NF-B induction by pre-
with the AP-1 consensus motif (Rao et al., 1997). ToTCR signals promotes the transition from stage III
determine if NFAT-R was important for mitogen-induced(CD25CD44) to stage IV (CD25CD44) (Voll et al.,
c-rel transcription, c-rel promoter-reporter constructs2000), a developmental phase during which pro-T cell
with NFAT-R intact (pRel-luc) or altered (pRelm-luc) togrowth and division is c-Myc dependent (Douglas et al.,
prevent NFAT binding were transfected into Jurkat2001; Iritani et al., 2002), we examined rela/c-rel/
T cells, which were then treated with PMA plus iono-thymocyte growth and proliferation. Stage III and stage
mycin, in the absence or presence of FK506 (FigureIV DN (CD4CD8HSAhi) thymocytes were isolated from
6B). Whereas PMA/ionomycin, a potent NFAT activator,rag-1/ mice engrafted with control (wt, c-rel/,
significantly upregulated pRel-luc transcription (lanes 5rela/, or c-rel/rela/) or rela/c-rel/ E12 fetal liver
and 6), this stimulus failed to activate pRelm-luc (lanehemopoietic progenitors. A block in rag-1/ thymocyte
12). Consistent with PMA/ionomycin-dependent induc-
development at stage III permits the unambiguous iden-
tion of pRel-luc acting via NFAT, FK506 blocked the
tification of donor-derived stage IV DN thymocytes,
induced transcription of pRel-luc (lane 9).
whereas distinguishing between stage III DN thymo- The nuclear complexes that bound NFAT-R were ex-
cytes of donor and host cell origin was not possible. amined by electrophoretic mobility shift assays (Figure
Forward scatter analysis (Figure 5A) revealed that the 6C). In quiescent T cells (lane 1), two complexes, C1
median size of control and rela/c-rel/ stage IV thy- and C2, bound a probe encompassing NFAT-R; C1 bind-
mocytes was equivalent and (as expected) larger than ing was highly reproducible but that of C2 was variable.
stage III cells. Cell cycle analysis (Figure 5B) demon- In response to anti-CD3/anti-CD28 Abs or PMA and io-
strated that the frequency of wt and rela/c-rel/ stage nomycin (not shown), a novel complex of slower mobility
IV cells in S or G2/M was similar, with more cell division (C3) induced within 30 min bound the NFAT-R probe
occurring during stage IV. Consistent with the normal (lane 2). Binding of C2 and C3 to NFAT-R was dependent
growth and division of rela/c-rel/ stage IV DN thymo- on the NFATc consensus motif, as the NFAT-Rm probe, in
cytes, the levels of c-myc mRNA measured by real- which conserved residues essential for NFATC binding
time RT-PCR were comparable in control and mutant were mutated, failed to bind either complex (lanes 3 and
CD25CD44 thymocytes (Figure 5C). These findings 4). Consistent with the mitogen-induced C3 complex
establish that in pro-T cells, c-Rel and RelA are dispensi- being dependent on NFAT activity, C3 binding to the
ble for growth, division, and c-myc expression. NFAT-R probe was inhibited by FK506 (Figure 6D). The
finding that NFATC1-specific antibodies supershifted
In Mature T Cells, Mitogen-Induced c-rel the C3 complex (Figure 6E) or inhibited binding of C3
Expression Is NFAT Dependent to NFAT-R (Supplemental Figure S2) confirmed that
Despite redundant roles for RelA and c-Rel in the control NFATC1 was indeed a component of this complex. The
of mitogen-induced c-myc expression and T cell growth, identity of the protein(s) in C2 remains unknown. Collec-
tively, these data indicate that the mitogenic inductionthe kinetics of c-myc mRNA induction coincided with
Rel/NF-B Control of c-myc-Dependent T Cell Growth
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Figure 5. Growth and c-myc Expression Are Normal in rela/c-rel/ Thymocytes
(A) The size of rela/c-rel/ DN thymocytes is normal. Forward light scatter profiles of viable wt or rela/c-rel/ CD25CD44 and CD25CD44
DN thymocytes.
(B) Cell cycle analysis of rela/c-rel/ DN thymocytes. The fraction of viable CD25CD44 and CD25CD44 wt and rela/c-rel/ DN
thymocytes in G0/G1 or S/G2 plus M. The data in (A) and (B) are each representative of two experiments.
(C) c-myc expression in DN thymocytes. c-myc expression in wt and rela/c-rel/ CD25CD44 and CD25CD44 DN thymocytes was
assessed by real-time RT-PCR. c-myc mRNA expression in wt and rela/c-rel/ CD25CD44 (stage III) and CD25CD44 (stage IV) cells is
represented as relative to levels observed in wt cells. c-myc levels in each RNA sample have been normalized relative to GAPDH mRNA
expression. The data represent the mean  SD of three experiments.
of c-rel transcription in T cells is directly controlled by expression in T cells, pharmacological inhibitors of
PKC (rottlerin) and NFAT (FK506) function were em-NFAT.
ployed to determine the relationship between PKC,
NFAT, RelA, c-rel, and c-myc in the control of mitogen-PKC Is Required for Mitogen-Induced
T Cell Growth induced T cell growth. First, the consequences of inhib-
iting PKC or NFAT for T cell growth were examinedAmong the intracellular signaling molecules important
for T cell proliferation induced by TCR and CD28 en- (Figure 6A). Whereas FK506 at a concentration sufficient
to inhibit the calcineurin-dependent activation of NFATgagement that are essential for the activation of the NF-
B and NFAT/AP1 pathways is the calcium-independent (Woo et al., 1990) did not block mitogenic growth, in the
presence of rottlerin, mitogen-stimulated T cells failedPKC isoform, PKC (Isakov and Altman, 2002). Given the
redundant roles of RelA and c-Rel in c-myc-dependent to increase in size. This finding prompted us to examine
if rottlerin inhibition of T cell growth was linked to im-T cell growth, coupled with NFAT regulation of c-rel
Immunity
26
Figure 6. In T Cells, Mitogen-Induced c-rel Transcription Is Directly Regulated by NFAT
(A) c-rel expression in T cells is NF-B independent. 5 g samples of total RNA from wt or nfkb1/rela/ T cells prior to or after anti-CD3/
anti-CD28 Ab activation for 1 hr was subjected to Northern blot analysis. Filters were hybridized with c-rel and GAPDH cDNA probes. The
data shown are representative of two experiments.
(B) Analysis of the murine c-rel promoter. Shown is a schematic diagram of the c-rel 5 flanking region and luciferase reporter plasmids. E1
and E2 correspond to exons; the hatched and closed regions of c-rel represent 5 untranslated and coding regions, respectively. The arrow
designates the major start site of transcription. Open boxes represent the B sites and putative NFAT element (5-TGGAAAGAGCTATGCCA-
3); the corresponding symbol with a cross represents the mutated NFAT motif (5-TTTAAAGAGCTATGTCA-3). The luciferase gene, luc, is
depicted as an open box. Jurkat T cells were transfected with reporter plasmids, and 24 hr later, cells were left untreated or stimulated for
6 hr with PMA/ionomycin, FK506, rottlerin, PMA/ionomycin/FK506, or PMA/ionomycin/rottlerin. Promoter activity is displayed as relative
luciferase units. The results represent the mean luciferase activity  SD from four sets of transfections.
(C) A mitogen-induced complex binds NFAT-R. Nuclear extracts from resting or anti-CD3/anti-CD28 Ab-activated (30 min) T cells were
incubated with radiolabeled NFAT-R or NFAT-Rm probes, then resolved on nondenaturing acrylamide gels. Shown are the inducible slow
mobility (C3) and constitutive fast mobility complexes (C1 and C2).
(D) FK506 inhibits the mitogen-inducible complex. Nuclear extracts from T cells that were resting or mitogen activated in the absence or
presence of FK506 were incubated with radiolabeled NFAT-R probe.
(E) The inducible C3 complex contains NFATC1. Nuclear extracts from activated T cells were incubated with irrelevant (lane 1) or NFATC1
(lane 2) specific sera. The supershifted C3 complex is indicated by the arrow.
paired c-myc expression (Figure 7B). While the upregu- block in T cell growth observed in the combined absence
of c-Rel and RelA suggested a mechanism involving thelation of c-myc in activated T cells was not affected by
FK506 (lane 3), rottlerin suppressed the induction of inhibition of both these transcription factors. Consistent
with PKC being necessary for RelA nuclear import (Sunc-myc (lane 4). The capacity of rottlerin to mimic the
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Figure 7. c-myc Dependent T Cell Growth Is
Regulated by PKC
(A) PKC inhibitor rottlerin blocks T cell
growth. Splenic T cells were untreated or
stimulated for 24 hr with anti-CD3/anti-CD28
Abs alone or in combination with FK506 or
rottlerin. Shown are forward light scatter pro-
files of viable unstimulated (closed) or acti-
vated (open) T cells (x axis). The data are
representative of three experiments.
(B) Rottlerin blocks mitogen-induced c-myc
expression. Total RNA isolated from wt T cells
that were untreated or stimulated (2 hr) with
anti-CD3/anti-CD28 Abs in the absence (lane
2) or presence of FK506 (lane 3) or rottlerin
(lane 4) was subjected to Northern blot analy-
sis. Filters were sequentially hybridized with
c-myc, c-rel, and GAPDH probes.
(C) Rottlerin, but not FK506, inhibits the nu-
clear import of RelA. Nuclear extracts from
wt T cells that were untreated or activated
for 30 min with anti-CD3/anti-CD28 Abs in the
absence (lanes 2–4) or presence of FK506
(lane 5) or rottlerin (lane 6). c-Rel- and RelA-
specific Abs were pre-incubated with nuclear
extract from activated T cells prior to adding
radiolabeled B probe. The mitogen-induced
complex is designated Ci.
et al., 2000), a nuclear complex (Ci) induced in T cells et al., 2002). Here, we extend this link to include mitogen-
activated T cells. While our findings are consistent withwithin 30 min of activation (Figure 7C, lane 2) containing
RelA (Figure 7C, lane 4) but not c-Rel (lane 3) was inhib- endogenous c-Myc inducing growth in primary B cells
(Morena de Alboran et al., 2001; Grumont et al., 2002)ited by rottlerin (lane 6). Furthermore, rottlerin prevented
the mitogen-induced expression of c-rel mRNA (Figure and thymocytes (Douglas et al., 2001), it contradicts a
report (Trumpp et al., 2001) that concluded that in T cells7B, lane 4) and inhibited PMA plus ionomycin-mediated
transcription of pRel-luc (Figure 6B, lane 10). In contrast c-Myc is dispensible for growth but instead regulates
cell cycle entry in response to mitogenic signals. Utiliz-to the action of rottlerin, FK506, while inhibiting c-rel
expression (Figure 7B, lane 3), did not prevent the nu- ing a mouse strain that expressed a single functional lox-
P-targeted c-myc allele and carried a Mx-Cre transgene,clear induction of RelA complexes (Figure 7C, lane 5).
These results are consistent with PKC being able to T cells lacking c-Myc were generated by in vivo admin-
istration of pIC (Trumpp et al., 2001). It was noted,control c-myc-dependent T cell growth by regulating
the nuclear translocation of RelA- and NFAT-mediated however, that this inducible deletion of c-myc was in-
complete, with 28%–48% of T cells isolated from thesec-rel transcription.
pIC-treated mice retaining the functional c-myc allele.
Given that an absence of c-Myc increases T cell deathDiscussion
during mitogen stimulation (Trumpp et al., 2001), a find-
ing consistent with high levels of apoptosis seen duringProminent in the control of gene expression during the
early stage of T cell activation are the NFAT and Rel/ rela/c-rel/ T cell activation (Figure 3C), the apparent
growth of mitogen-stimulated c-myc null T cells ob-NF-B transcription factors. A detailed understanding
of the precise physiological roles served by the Rel/NF- served in the study by Trumpp may instead reflect the
preferential survival of T cells retaining a functionalB transcription factors in this process is complicated
by functional redundancy (Gerondakis et al., 1999) and c-myc allele.
The findings presented here for T cells, together withtemporal changes in nuclear expression of different Rel/
NF-B dimers (Molitor et al., 1990). Using T cells that lack a report on B cell growth (Grumont et al., 2002), establish
that the Rel/NF-B pathway serves a common role con-different combinations of the major Rel/NF-B factors
normally activated in the response to mitogens, we show trolling c-myc-dependent growth of mitogen-activated
lymphocytes. In the T lineage, the link between RelA/that c-myc-dependent T cell growth is controlled by
RelA and c-Rel via PKC- and NFAT-dependent path- c-Rel, c-myc, and growth appears to be restricted to
mature T cells, with cell growth, division, and c-mycways that coordinate RelA nuclear import and induced
c-rel transcription. expression found to be normal in rela/c-rel/ thymo-
cytes. Moreover, normal growth of nfkb1/rela/ andA body of evidence gathered from different experi-
mental systems indicate that c-Myc regulates the mito- nfkb1/c-rel/DN thymocytes (results not shown) indi-
cates that this function may be Rel/NF-B independent.genic induction of cell growth (Eisenman, 2001; Iritani
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Given the inhibition of Rel/NF-B function increases growth is, however, cell type specific, with cardiomyo-
CD25CD44 DN thymocyte apoptosis (Voll et al., 2000), cyte growth blocked in the absence of NFATC2 (Horsley
this indicates that the role of this pathway in thymocyte and Parlath, 2002). In contrast, PKC is essential for
homeostasis is one of cell survival rather than division. T cell growth. Although the inhibition of mitogen-
Functional overlap between c-Rel and other Rel/NF- induced growth and c-myc expression by rottlerin coin-
B family members in controlling c-myc-induced growth cides with a combined block in RelA nuclear transloca-
differs between B and T cells. Whereas c-Rel and RelA tion and c-rel transcription, we cannot rule out that rottl-
are required for c-myc expression in T cells, c-Rel and erin inhibition of growth may involve PKC targets other
NF-B1 serve this role in B cells (Grumont et al., 2002). than NFAT/AP-1 and NF-B. Finally, the link established
The reason for this lineage-specific difference remains here between PKC and the c-Rel/RelA-dependent con-
to be determined but may be related to a hierarchy of trol of c-myc-mediated T cell growth may have implica-
importance among these transcription factors in B and tions for cancer therapy. Deregulated Rel/NF-B signal-
T cells, a notion supported by a predominance of NF- ing, a hallmark of many lymphoid cancers (Rayet and
B1/c-Rel in mature B cells but not T cells (Gugasyan Gelinas, 1999), is likely to be important in cancer cell
et al., 2000). Despite functional overlap between c-Rel proliferation. Given that PKC expression is largely re-
and RelA in growth control, the kinetics of induced stricted to mature T cells (Isakov and Altman, 2002),
c-myc expression in T cells coincide with the nuclear our study indicates that targeting PKC function could
expression of c-Rel, not RelA. Why then Rel/NF-B- disrupt the growth and division of T cell leukemias with
dependent T cell growth is not controlled by c-Rel alone high levels of Rel/NF-B activity that display a mature
is at present unclear. We have also found that enforced T cell phenotype.
c-Myc expression, while able to overcome the block in
Experimental Proceduresgrowth afflicting rela/c-rel/ T cells, is insufficient to
rescue the mitogen-induced proliferation of these mu-
Micetant T cells (Supplemental Figure S3). This indicates that
c-rel/, nfkb1/, nfkb1/c-rel/, and vav-bcl-2 mice on a C57BL6RelA and c-Rel serve functions in addition to promoting
background have been described (Grossmann et al., 2000; Grumont
growth that are essential for T cell proliferation, akin to et al., 2002). The rela/, nfkb1/rela/, and rela/c-rel/ parental
the multiple roles of Rel/NF-B in B cell activation and strains used to generate rela/, nfkb1/rela/, and c-rel/rela/
proliferation (Grumont et al., 2002). embryos were derived from mice backcrossed onto C57BL/6 (n 	
9–10 backcross generations).Our study shows that mitogen-induced c-rel tran-
scription in T cells is regulated by a PKC/NFAT-depen-
Fetal Liver Cell Engraftmentdent pathway. Although FK506 inhibition of c-rel expres-
Splenic T lymphocytes of all genotypes (wt, nfkb1/, c-rel/,sion in T cells (Venkataraman et al., 1995) had implicated
rela/, nfkb1/c-rel/, nfkb1/rela/, rela/c-rel/, vav-bcl-2,
NFAT in the control of c-rel, our identification of a con- and rela/c-rel/vav-bcl2) were generated by engrafting rag-1/
sensus NFAT element in the murine c-rel promoter that mice with E12 fetal liver hemopoietic progenitors as described
(Grossmann et al., 2000).bound NFATC1 and was required for c-rel transcription
establishes c-rel as a direct transcriptional target of
Purification of T Cells and ThymocytesNFAT. Furthermore, we show that PKC, which is re-
Purified splenic T cells were obtained by cell sorting on a FACStarquired for the expression of AP-1 (Pfeifhofer et al., 2003),
Plus (Becton Dickinson, CA) after staining with anti-Thy-1 antibod-
a component of NFAT, was also necessary for c-rel ies. The purity of all sorted splenic T cell populations was 
97%.
expression. Even though PKC lies upstream of both Double-negative (CD4CD8HSAhi) thymocytes purified from rag-1/
the NF-B and NFAT pathways, our findings indicate its mice reconstituted with control or rela/c-rel/ fetal liver hemopoi-
role in c-rel transcription is mediated through NFAT. etic progenitors first involved the depletion of unwanted cells by
negative cell sorting (O’Reilly et al., 1997). The remaining cells wereImportantly, our findings suggest that during the early
stained with CD25 and CD44 mAbs, then sorted into CD25CD44stages of T cell activation, a regulatory hierarchy exists
(stage III) and CD25CD44 (stage IV) populations, the purity ofbetween NFAT and the c-Rel component of the NF-B
which was 
95%.
pathway, which is coordinated by PKC. The integration
of these two signaling pathways through NFAT regula- Cell Stimulation
tion of c-rel transcription may offer an additional mecha- Purified splenic T cells (5  105/ml) were stimulated with PMA (2 ng/
nism for controlling the expression of genes such as ml) plus ionomycin (1 g/ml) or plate bound anti-CD3 (10 g/ml)
and anti-CD28 (10 g/ml) mAbs in the absence or presence of exog-IL-2 and GM-CSF, which are coregulated in T cells by
enous IL-2 (500 U/ml). FK506 and rottlerin (Calbiochem, La Jolla,these two families of transcription factors (Gerondakis
CA) were added to cultures at final concentrations of 0.5 M andet al., 1996; Rao et al., 1997, 2003).
5 M, respectively.Although mitogen-induced T cell growth is not
blocked by concentrations of FK506 sufficient to inhibit Flow Cytometric and Cell Cycle Analysis
c-rel expression, we noted that at a 10-fold greater Cultured T cells that were untreated or mitogen activated for 24 hr
concentration (5 M), FK506 does block T cell growth. were stained with PI, and the forward light scatter profile of viable
cells was determined by flow cytometry as described (Grumont etImportantly, this failure of T cells to grow was not associ-
al., 2002). Cell division in purified thymocyte populations and inated with an inhibition of nuclear RelA or c-myc expres-
mitogen-stimulated T cell cultures was determined by assessingsion (R.G., unpublished results) and instead may be due
DNA content using PI staining (Grumont et al., 1998).to calcineurin-independent effects of FK506 (Halloran
et al., 1998). Such a conclusion is consistent with T cell DNA, RNA, and Protein Synthesis Assays
growth not being affected by an absence of various T cells (3  105 cells/ml) cultured in 100 l of medium (DMEM/10%
NFAT family members (Peng et al., 2001; Yoshida et al., FCS/50 M ME) in 96-well microtiter plates were stimulated with
mitogens and at various times DNA synthesis was measured by1998; Rengarajan et al., 2002). A role for NFAT in cell
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adding 0.5 Ci of [3H]thymidine for 6 hr. For RNA synthesis, cultures 2001). For semiquantitative PCR, cDNA was first denatured at 94C
for 5 min, then amplification was performed for 25 cycles with eachwere pulsed 12 hr after mitogenic activation with 0.25 Ci of [3H]uri-
dine for an additional 6 hr. In both cases, incorporated radioactivity cycle programmed for denaturation at 94C for 45 s, annealing at
58C for 60 s, followed by elogation at 72C for 90 s. Samples weremeasured by scintillation counting. Cellular protein concentrations
in T cells was determined by the Bradford assay. then fractionated on a 1.0% agarose gel. The sequences of the
oligonucleotides used for the amplification of -actin and retrovirus-
encoded c-myc were viral c-myc (forward, 5-CAAAGTAGACGGNorthern Blotting
CATCGCAGCTT-3, pMY-EGFP vector; reverse, 5-ATTTGGGC10g samples of total RNA isolated from purified resting or activated
GAGCTGCTGTCGTTCA-3, mouse c-myc exon 2; product size 717splenic T cells were subjected to Northern blot analysis (Grumont
bp) and -actin (forward, 5-CTGAAGTACCCATTGAACATGGC-3;et al., 2002). Probes were a mouse 1.4 kb Xho1 c-myc cDNA, a rat
reverse, 5-CAGAGCAGTAATCTCCTTCTGCAT-3; product size 7261.1 kb Pst glyceraldehyde-3-phosphate-dehydrogenase (GAPDH)
bp). Endogenous c-myc expression in double-negative thymocytescDNA, and a mouse 2.9 kb EcoR1 c-rel cDNA.
was measured using SYBR green real-time PCR reactions as de-
scribed (Rao et al., 2003). c-myc mRNA levels were normalized byWestern Blotting
taking an aliquot of each sample and performing quantitiative PCRTotal cellular RelA levels were monitored in MY-EGFPrela virus-
for GAPDH mRNA expression to compensate for input RNA variationinfected T cells (2  105/sample) by Western blotting (Grumont et
and inefficiencies in cDNA synthesis. Primer sets used for real-timeal., 2002) using a RelA-specific antisera (Grumont and Geron-
PCR were c-myc (forward, 5-ACCAACAGGAACTATGACCTC-3;dakis, 1994).
reverse, 5-AAGGACGTAGCGACCGCAAC-3) and GAPDH (forward,
5-TTCACCACCATGGAGAAGGC-3; reverse, 5-GGCATGGACTGTPlasmid Constructs
GGTCATGA-3).The plasmid pRel-luc comprised a 2.64 kb genomic fragment that
encompassed the mouse c-rel 5 untranslated sequence, transcrip-
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